Mathematical models in percutaneous absorption

A number of mathematical models have been used to describe percutaneous absorption kinetics. In general, most of these models have used either diffusion-based or compartmental equations. The object of any mathematical model is to a) be able to represent the processes associated with absorption accurately, b) be able to describe/summarize experimental data with parametric equations or moments, and c) predict kinetics under varying conditions. However, in describing the processes involved, some developed models often suffer from being of too complex a form to be practically useful. In this chapter, we attempt to approach the issue of mathematical modeling in percutaneous absorption from four perspectives. These are to a) describe simple practical models, b) provide an overview of the more complex models, c) summarize some of the more important/useful models used to date, and d) examine sonic practical applications of the models. The range of processes involved in percutaneous absorption and considered in developing the mathematical models in this chapter is shown in Fig. 1. We initially address in vitro skin diffusion models and consider a) constant donor concentration and receptor conditions, b) the corresponding flux, donor, skin, and receptor amount-time profiles for solutions, and c) amount- and flux-time profiles when the donor phase is removed. More complex issues, such as finite-volume donor phase, finite-volume receptor phase, the presence of an efflux. rate constant at the membrane-receptor interphase, and two-layer diffusion, are then considered. We then look at specific models and issues concerned with a) release from topical products, b) use of compartmental models as alternatives to diffusion models, c) concentration-dependent absorption, d) modeling of skin metabolism, e) role of solute-skin-vehicle interactions, f) effects of vehicle loss, a) shunt transport, and h) in vivo diffusion, compartmental, physiological, and deconvolution models. We conclude by examining topics such as a) deep tissue penetration, b) pharmacodynamics, c) iontophoresis, d) sonophoresis, and e) pitfalls in modeling.

[1]  Sugibayashi Kenji,et al.  Prediction of skin permeability of drugs. II. Development of composite membrane as a skin alternative , 1992 .

[2]  J. Shah Application of kinetic model to in vitro percutaneous permeation of drugs , 1996 .

[3]  M. Roberts,et al.  Importance of dermal blood supply and epidermis on the transdermal iontophoretic delivery of monovalent cations. , 1995, Journal of pharmaceutical sciences.

[4]  A. Michaels,et al.  Scopolamine permation through human skin in vitro , 1976 .

[5]  S. Mitragotri,et al.  An explanation for the variation of the sonophoretic transdermal transport enhancement from drug to drug. , 1997, Journal of pharmaceutical sciences.

[6]  R. Purves Accuracy of numerical inversion of Laplace transforms for pharmacokinetic parameter estimation. , 1995, Journal of pharmaceutical sciences.

[7]  R. Guy,et al.  A theoretical description of the effects of volatility and substantivity on percutaneous absorption , 1984 .

[8]  J L Fox,et al.  Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development. , 1979, Journal of pharmaceutical sciences.

[9]  E R Cooper,et al.  Finite dose pharmacokinetics of skin penetration. , 1985, Journal of pharmaceutical sciences.

[10]  R. Langer,et al.  A linear theory of transdermal transport phenomena. , 1994, Journal of pharmaceutical sciences.

[11]  K Kubota A compartment model for percutaneous drug absorption. , 1991, Journal of pharmaceutical sciences.

[12]  Y. Kalia,et al.  Characterization of the permeability barrier of human skin in vivo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. W. Jepson,et al.  Physiologically based modeling of nonsteady state dermal absorption of halogenated methanes from an aqueous solution. , 1997, Toxicology and applied pharmacology.

[14]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. , 1973, The Journal of investigative dermatology.

[15]  P. J. Robinson PREDICTION : SIMPLE RISK MODELS AND OVERVIEW OF DERMAL RISK ASSESSMENT , 1998 .

[16]  J. Fox,et al.  Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate II: Parameter determinations. , 1979, Journal of pharmaceutical sciences.

[17]  E. H. Twizell,et al.  Dual sorption model for the nonlinear percutaneous permeation kinetics of timolol. , 1993, Journal of pharmaceutical sciences.

[18]  McCarley,et al.  Physiologically relevant one-compartment pharmacokinetic models for skin. 1. Development Of models , 1998, Journal of pharmaceutical sciences.

[19]  E. R. Cooper Effect of diffusional lag time on multicompartmental pharmacokinetics for transepidermal infusion. , 1979, Journal of pharmaceutical sciences.

[20]  S. E. Cross,et al.  Effect of Perfusion Flow Rate on the Tissue Uptake of Solutes After Dermal Application Using the Rat Isolated Perfused Hindlimb Preparation , 1994, The Journal of pharmacy and pharmacology.

[21]  W. Higuchi,et al.  Theoretical analysis of diffusional movement through heterogeneous barriers , 1960 .

[22]  M. Roberts,et al.  Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults. , 1999, British journal of clinical pharmacology.

[23]  M. Roberts,et al.  Blood flow measurements in skin and underlying tissues by microsphere method: application to dermal pharmacokinetics of polar nonelectrolytes. , 1993, Journal of pharmaceutical sciences.

[24]  H. Maibach,et al.  Percutaneous absorption: a single-layer model. , 1993, Journal of pharmaceutical sciences.

[25]  D. Taylor,et al.  Comparison of oral and percutaneous routes in man for the systemic administration of 'ephedrines'. , 1972, The Journal of pharmacy and pharmacology.

[26]  J. Fox,et al.  The effects of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin. II. A new quantitative approach☆ , 1987 .

[27]  Jonathan Hadgraft,et al.  Percutaneous metabolism with saturable enzyme kinetics , 1982 .

[28]  M. Hashida,et al.  Analysis of skin penetration enhancement based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities. , 1993, Biological & pharmaceutical bulletin.

[29]  H. Maibach,et al.  Modelling of plasma levels of drugs following transdermal iontophoresis , 1995 .

[30]  H. Maibach,et al.  Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent. , 1995, Journal of pharmaceutical sciences.

[31]  Jonathan Hadgraft,et al.  The epidermal reservoir; A theoretical approach , 1979 .

[32]  J. Hadgraft,et al.  PHYSICOCHEMICAL DETERMINANTS OF STRATUM CORNEUM PERMEATION , 1998 .

[33]  J. Hadgraft,et al.  IN VITRO/IN VIVO CORRELATIONS IN TRANSDERMAL DRUG DELIVERY , 1998 .

[34]  Jeffrey L. Fox,et al.  General physical model for simultaneous diffusion and metabolism in biological membranes. The computational approach for the steady-state case , 1979 .

[35]  N. Benowitz,et al.  Stable isotope method for studying transdermal drug absorption: The nicotine patch , 1991, Clinical pharmacology and therapeutics.

[36]  R. Scheuplein Permeability of the skin: a review of major concepts. , 1976, Current problems in dermatology.

[37]  J. Fox,et al.  Physical model evaluation of topical prodrug delivery--simultaneous transport and bioconversion of vidarabine-5'-valerate V: Mechanistic analysis of influence of nonhomogeneous enzyme distributions in hairless mouse skin. , 1980, Journal of pharmaceutical sciences.

[38]  M. Reddy,et al.  Physiologically relevant one-compartment pharmacokinetic models for skin. 2. Comparison of models when combined with a systemic pharmacokinetic model. , 1998, Journal of pharmaceutical sciences.

[39]  Y. Chien,et al.  Drug permeation across the skin: effect of penetrant hydrophilicity. , 1987, Journal of pharmaceutical sciences.

[40]  A. Bunge,et al.  Physiologically relevant two-compartment pharmacokinetic models for skin. , 2000, Journal of pharmaceutical sciences.

[41]  R. Guy,et al.  Percutaneous absorption: multidose pharmacokinetics , 1983 .

[42]  M. Roberts,et al.  THE RELATIONSHIP BETWEEN STRUCTURE AND BARRIER FUNCTION OF SKIN , 1998 .

[43]  E. Koyama,et al.  A random walk method for percutaneous drug absorption pharmacokinetics: application to repeated administration of a therapeutic timolol patch. , 1991, Journal of pharmaceutical sciences.

[44]  M. Wu Determination of concentration-dependent water diffusivity in a keratinous membrane. , 1983, Journal of pharmaceutical sciences.

[45]  H. Maibach,et al.  SITE OF EFFECTS , 1998 .

[46]  T. Yamada,et al.  Finite dose percutaneous drug absorption: theory and its application to in vitro timolol permeation. , 1990, Journal of pharmaceutical sciences.

[47]  H. Ando,et al.  Skin as an active metabolizing barrier I: Theoretical analysis of topical bioavailability. , 1977, Journal of pharmaceutical sciences.

[48]  M. Roberts,et al.  Permeability of human epidermis to phenolic compounds , 1977, The Journal of pharmacy and pharmacology.

[49]  Jonathan Hadgraft,et al.  Theoretical aspects of metabolism in the epidermis , 1980 .

[50]  E. Contreras,et al.  Effect of drugs that modify 3‘,5’‐AMP concentrations on morphine analgesia , 1972, The Journal of pharmacy and pharmacology.

[51]  P. Robinson,et al.  In vitro skin evaporation and penetration characteristics of mosquito repellents. , 1982, Journal of pharmaceutical sciences.

[52]  W. Higuchi Diffusional Models Useful in Biopharmaceutics: Drug Release Rate Processes , 1967 .

[53]  R. Guy,et al.  Percutaneous absorption kinetics of topically applied agents liable to surface loss , 1984 .

[54]  R. Guy,et al.  A theoretical description relating skin penetration to the thickness of the applied medicament , 1980 .

[55]  J Hadgraft,et al.  Prediction of drug disposition kinetics in skin and plasma following topical administration. , 1984, Journal of pharmaceutical sciences.

[56]  P. Williams,et al.  A physiologically relevant pharmacokinetic model of xenobiotic percutaneous absorption utilizing the isolated perfused porcine skin flap. , 1990, Journal of pharmaceutical sciences.

[57]  Jonathan Hadgraft,et al.  The effect of penetration enhancers on the kinetics of percutaneous absorption , 1987 .

[58]  K. Yamaoka,et al.  A nonlinear least squares program, MULTI(FILT), based on fast inverse Laplace transform for microcomputers. , 1989, Chemical & pharmaceutical bulletin.

[59]  E. R. Cooper Pharmacokinetics of skin penetration. , 1976, Journal of pharmaceutical sciences.

[60]  J E Shaw,et al.  Pharmacokinetics of drug permeation through human skin. , 1978, Journal of pharmaceutical sciences.

[61]  Howard I. Maibach,et al.  A pharmacokinetic model for percutaneous absorption , 1982 .

[62]  J. N. Mcdougal,et al.  PREDICTION : PHYSIOLOGICAL MODELS , 1998 .

[63]  J. Hadgraft Calculations of drug release rates from controlled release devices. The slab , 1979 .

[64]  S. Riegelman Pharmacokinetics; Pharmacokinetic factors affecting epidermal penetration and percutaneous absorption , 1974, Clinical pharmacology and therapeutics.

[65]  R. A. Anderson,et al.  The percutaneous absorption of phenolic compounds: the mechanism of diffusion across the stratum corneum , 1978, The Journal of pharmacy and pharmacology.

[66]  H. Merkle,et al.  Modeling and numerical computation of drug transport in laminates: model case evaluation of transdermal delivery system. , 1986, Journal of pharmaceutical sciences.

[67]  Gerald B. Kasting,et al.  Theoretical models for iontophoretic delivery , 1992 .

[68]  J. Westwater,et al.  The Mathematics of Diffusion. , 1957 .

[69]  G. Barton The Mathematics of Diffusion 2nd edn , 1975 .

[70]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. , 1967, The Journal of investigative dermatology.

[71]  R. Guy,et al.  Pharmacokinetics of percutaneous absorption with concurrent metabolism , 1984 .

[72]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. , 1974, The Journal of investigative dermatology.